Gene therapy for metabolic diseases
Translational Science of Rare Diseases · 2016
DOI: 10.3233/trd-160007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Science of Rare Diseases, 2016. Verfasst von Randy J Chandler und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Gene therapy has recently shown great promise as an effective treatment for a number of metabolic diseases caused by genetic defects in both animal models and human clinical trials. Most of the current success has been achieved using a viral mediated gene addition approach, but gene-editing technology has progressed rapidly and gene modification is being actively pursued in clinical trials. This review focuses on viral mediated gene addition approaches, because most of the current clinical trials utilize this approach to treat metabolic diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Förderung
- Intramural NIH HHS
Zitieren
APA
Chandler, R. J., & Venditti, C. P. (2016). Gene therapy for metabolic diseases. Translational Science of Rare Diseases. https://doi.org/10.3233/trd-160007
Vancouver
Chandler RJ, Venditti CP. Gene therapy for metabolic diseases. Translational Science of Rare Diseases. 2016. doi:10.3233/trd-160007
BibTeX
@article{Chandler2016,
author = {Chandler, Randy J and Venditti, Charles P},
title = {Gene therapy for metabolic diseases},
journal = {Translational Science of Rare Diseases},
year = {2016},
doi = {10.3233/trd-160007}
}
EUVIMED